Article Details
Retrieved on: 2025-03-17 14:11:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
These data demonstrate the breadth of Roche's neuromuscular portfolio across spinal muscular atrophy (SMA) and Duchenne muscular dystrophy (DMD). This ...
Article found on: www.marketscreener.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here